ClinicalTrials.govpublic full text
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
diabetes mellitus, type 2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 226234
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.